Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-25-000196
Filing Date
2025-02-06
Accepted
2025-02-06 14:14:49
Documents
40
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q welsis_10q.htm   iXBRL 10-Q 312953
2 CERTIFICATION welsis_ex311.htm EX-31.1 10375
3 CERTIFICATION welsis_ex321.htm EX-32.1 4629
  Complete submission text file 0001640334-25-000196.txt   1594646

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA welsis-20241231.xsd EX-101.SCH 18586
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE welsis-20241231_lab.xml EX-101.LAB 108928
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE welsis-20241231_cal.xml EX-101.CAL 22315
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE welsis-20241231_pre.xml EX-101.PRE 82693
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE welsis-20241231_def.xml EX-101.DEF 21279
43 EXTRACTED XBRL INSTANCE DOCUMENT welsis_10q_htm.xml XML 116840
Mailing Address 701 E CATHEDRAL RD STE 45 PMB 405 PHILADELPHIA PA 19128
Business Address 701 E CATHEDRAL RD STE 45 PMB 405 PHILADELPHIA PA 19128 215-552-8991
Welsis Corp. (Filer) CIK: 0001887912 (see all company filings)

EIN.: 000000000 | State of Incorp.: WY | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-56527 | Film No.: 25596786
SIC: 8000 Services-Health Services
(CF Office: 08 Industrial Applications and Services)